{
  "report_rows": [
    {
      "kpi": "Q2 2026 adjusted diluted EPS",
      "prediction": "BEAT",
      "answer": "pred ~$2.11 vs. cons $2.08",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 reported revenue",
      "prediction": "IN-LINE",
      "answer": "pred ~$4.43B vs. cons $4.39B",
      "confidence": "MEDIUM"
    },
    {
      "kpi": "Q2 2026 organic sales growth",
      "prediction": "BEAT",
      "answer": "pred ~4.6% vs. cons 4.2%",
      "confidence": "MEDIUM"
    }
  ],
  "guide_rows": [
    {
      "kpi": "Adjusted diluted EPS including CoolIT",
      "prediction": "LOWER",
      "answer": "guide ~$8.13 vs. cons $8.18 (FY2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Organic sales growth",
      "prediction": "UNCHANGED",
      "answer": "guide ~6.5% vs. cons 6.5% (H2 2026)",
      "confidence": "HIGH"
    },
    {
      "kpi": "Organic gross-margin expansion",
      "prediction": "UNCHANGED",
      "answer": "guide ~75 bps vs. cons 75 bps (H2 2026)",
      "confidence": "MEDIUM"
    }
  ],
  "day1_residual_pct": 1.4,
  "day1_confidence": "MEDIUM",
  "day5_residual_pct": 0.3,
  "day5_path": "FADE",
  "day5_rationale": "The Q2 EPS beat of ~$2.11 vs. $2.08 consensus supports the initial reaction, but FY2026 EPS guidance of ~$8.13 vs. $8.18 consensus implies modest H2 estimate pressure, causing most of the day-1 gain to fade.",
  "day5_confidence": "MEDIUM"
}